These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 2789176)
1. Human immunosuppressive factors produced by T cell hybridoma. Tsunetsugu-Yokota Y; Honda M; Tokunaga T Hybridoma; 1989 Aug; 8(4):391-400. PubMed ID: 2789176 [TBL] [Abstract][Full Text] [Related]
2. Human suppressor factors constitutively produced by T-T cell hybridomas: functional and biochemical characterization. Kunicka JE; Calvelli TA; Fox FE; Steinberg J; Telerman A; Platsoucas C Hybridoma; 1989 Apr; 8(2):127-51. PubMed ID: 2785481 [TBL] [Abstract][Full Text] [Related]
3. Hybridoma-derived human suppressor factors: inhibition of growth of tumor cell lines and effect on cytotoxic cells. Kunicka JE; Fox FE; Seki H; Oleszak EL; Platsoucas CD Hum Antibodies Hybridomas; 1991 Jul; 2(3):160-9. PubMed ID: 1873505 [TBL] [Abstract][Full Text] [Related]
4. Human hybridoma-derived suppressor factor 160 and transforming growth factor-beta are different molecules. Fox FE; Oleszak EL; Chen PF; Platsoucas CD Lymphokine Cytokine Res; 1992 Dec; 11(6):307-15. PubMed ID: 1477184 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of interleukin 2 production and alteration of interleukin 2 mRNA processing by human T-T cell hybridoma-derived suppressor factors. Fox FE; Chernajovsky Y; Platsoucas CD Hybridoma; 1994 Oct; 13(5):343-52. PubMed ID: 7860090 [TBL] [Abstract][Full Text] [Related]
6. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes. Fujiwara H; Toossi Z; Ohnishi K; Edmonds K; Ellner JJ J Immunol; 1987 Jan; 138(1):197-203. PubMed ID: 3097146 [TBL] [Abstract][Full Text] [Related]
8. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. IV. Murine T hybridoma cells exhibit differential accessory cell requirements for activation by M. arthritidis T cell mitogen, concanavalin A, or hen egg-white lysozyme. Cole BC; Araneo BA; Sullivan GJ J Immunol; 1986 May; 136(10):3572-8. PubMed ID: 3486214 [TBL] [Abstract][Full Text] [Related]
9. Soluble factors secreted by naturally occurring suppressor cells that interfere with in vivo graft-vs.-host disease and with T cell responsiveness in vitro. Knaan-Shanzer S; Van Bekkum DW Eur J Immunol; 1987 Jun; 17(6):827-34. PubMed ID: 2954829 [TBL] [Abstract][Full Text] [Related]
10. Characterization of an immunosuppressive factor derived from colon cancer cells. Ebert EC; Roberts AI; O'Connell SM; Robertson FM; Nagase H J Immunol; 1987 Apr; 138(7):2161-8. PubMed ID: 3104453 [TBL] [Abstract][Full Text] [Related]
11. T cell inhibitor secreted by macrophages and endothelial cells. Kashiwado T; Oppenheimer-Marks N; Ziff M Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 1):137-50. PubMed ID: 2676271 [TBL] [Abstract][Full Text] [Related]
14. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses. Chiba K; Nishimura T; Hashimoto Y J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017 [TBL] [Abstract][Full Text] [Related]
15. Subtractive antibody to a human immunosuppressive lymphokine affinity isolates a suppressive factor and blocks its function. Haghighi AZ; Cathcart MK Immunopharmacology; 1992; 24(1):65-76. PubMed ID: 1452444 [TBL] [Abstract][Full Text] [Related]
16. The generation of stable human T-cell hybridomas which constitutively produce interleukin-2 and chemotactic factor. Foon KA; Rossio JL; Schroff RW; Wahl SM; Ruscetti FW; Abrams PG; Rager HC; Pickeral SF; Fidler IJ Hybridoma; 1985; 4(3):211-22. PubMed ID: 3930388 [TBL] [Abstract][Full Text] [Related]
17. Biological properties of suppressive E-receptor factor on lymphokine function. Oh SK; Leung MF; Knee T; Williams JM Eur J Immunol; 1987 Oct; 17(10):1403-9. PubMed ID: 3119348 [TBL] [Abstract][Full Text] [Related]
18. Identification of lacrimal gland associated immunomodulatory activities having differential effects on T and B cell proliferative responses. Pockley AG; Montgomery PC Reg Immunol; 1990-1991; 3(4):198-203. PubMed ID: 2129605 [TBL] [Abstract][Full Text] [Related]
19. A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination. Proust JJ; Buchholz MA; Nordin AA J Immunol; 1985 Jan; 134(1):390-6. PubMed ID: 3871110 [TBL] [Abstract][Full Text] [Related]
20. Establishment of a human T cell hybridoma cell line producing suppressor factor specific for anti-thyroglobulin antibody production. Noma T; Yata J J Immunol; 1987 May; 138(9):2929-34. PubMed ID: 3494775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]